pomolic-acid and Carcinoma--Hepatocellular

pomolic-acid has been researched along with Carcinoma--Hepatocellular* in 1 studies

Other Studies

1 other study(ies) available for pomolic-acid and Carcinoma--Hepatocellular

ArticleYear
(24S)-ergostane-3β,5α,6β-triol from Hedyotis chrysotricha with inhibitory activity on migration of SK-HEP-1 human hepatocarcinoma cells.
    Natural product research, 2013, Volume: 27, Issue:12

    The methanol extract of the whole plant of Hedyotis chrysotricha demonstrated cytotoxicity against SK-HEP-1 human hepatocarcinoma cells in a primary screening for novel antitumour agents. Bioassay-guided fractionation and purification led to an active principle (24S)-ergostane-3β,5α,6β-triol (1) along with four inactive compounds (2-5). The in vitro transwell migration assay showed that compound 1 remarkably reduced the migration of SK-HEP-1 cells by 78.9% at a dose of 30 µM, without any apoptotic effect on this cell line. Moreover, all the isolated compounds were further evaluated for their cytotoxicities against another four human cancer cell lines (MCF-7, NUGC3, SH-SY5Y and PC-3).

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Drug Screening Assays, Antitumor; Ergosterol; Hedyotis; Humans; Inhibitory Concentration 50; Liver Neoplasms; Medicine, Chinese Traditional; Molecular Structure; Oleanolic Acid; Plants, Medicinal

2013